MarketFriction

Gujarat Kidney & Super Speciality Ltd

NSE GKSL · BSE 544666 · Hospital
₹194.27 +8.50%
NSE close2026-10-01
52 week range98.36 - 186.99
Market cap₹1,394 Cr.
P/E88.0
IPO 2025 · +70% since Price band 20% Delivery 4.7%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales9.4111.799.7815.2612.9323.2530.5834.29
Expenses4.557.197.176.647.8116.3524.2825.92
Operating Profit4.864.602.618.625.126.906.308.37
OPM %51.65%39.02%26.69%56.49%39.60%29.68%20.60%24.41%
Other Income0.040.050.050.010.090.060.710.69
Interest0.160.170.160.180.280.600.820.66
Depreciation0.740.880.900.960.901.331.511.44
Profit before tax4.003.601.607.494.035.034.686.96
Tax %26.25%29.72%16.88%27.77%28.54%26.44%-2.99%23.56%
Net Profit2.962.531.345.402.883.704.825.32
EPS in Rs18.3915.530.230.850.470.370.640.66
Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales054082101
Expenses03245574
Operating Profit-02172727
OPM %41%41%33%26%
Other Income01012
Interest00122
Depreciation00355
Profit before tax-02132121
Tax %0%25%26%21%
Net Profit-02101717
EPS in Rs-0.5085.501.661.972.14
Dividend Payout %0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%%%119%
Compounded Profit Growth%%1058%37%
Stock Price CAGR%%%%
Return on Equity%%16%11%
Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.200.201116
Reserves01115237
Borrowings06829
Other Liabilities442116
Total Liabilities42155298
Fixed Assets01431129
CWIP0000
Investments00012
Other Assets4724157
Total Assets42155298
Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity0114-4
Cash from Investing Activity00-18-214
Cash from Financing Activity0-06228
Net Cash Flow01211
Free Cash Flow02-5-98
CFO/OP0%70%99%21%
Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days321138172
Inventory Days
Days Payable
Cash Conversion Cycle321138172
Working Capital Days100-2491
ROCE %19%52%14%
Dec 2025Mar 2026Jun 2026
Promoters71.45%71.45%71.45%
FIIs10.47%4.89%4.89%
DIIs1.67%0.56%0.56%
Public16.40%23.10%23.10%
No. of Shareholders27,78318,30118,301

Fundamentals

Market Cap₹ 1,394 Cr.
Current Price₹ 176
Stock P/E88.0
Book Value₹ 32.0
ROCE14.5 %
ROE11.1 %
Dividend Yield0.00 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)119%
Compounded Profit Growth (TTM)37%
Consolidated figures.
Ownership
Promoter holding71.45%
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
PeriodGKSLNifty 50Difference
1 week+13.7%-2.8% +16.5 pts
1 month+19.6%-6.8% +26.4 pts
3 months+49.6%-7.6% +57.3 pts
6 months+91.7%+0.4% +91.3 pts
1 mutual fund schemes hold about ₹0 Cr. Over three months 0 bought more and 1 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Bandhan BSE Healthcare Index Fund0.02%0 -22%

Red flags

No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹34 Cr +124.7% vs Jun 2025. Net profit ₹5 Cr -1.5%.

Activity

Compare
DateClientSideQtyPrice
2026-10-01Vinsul Makardi LtdSELL815,778198.74
2026-10-01Vinsul Makardi LtdBUY815,778198.41
2026-10-01Stackin Private LimitedSELL555,811197.94
2026-10-01Stackin Private LimitedBUY555,811197.66
2026-10-01Qe Securities LlpSELL933,215197.68
2026-10-01Qe Securities LlpBUY942,710197.12
2026-10-01Priyal BohraSELL399,546193.41
2026-10-01Priyal BohraBUY399,546195.84
2026-10-01Nk Securities Research Private LimitedSELL1,030,937199.93
2026-10-01Nk Securities Research Private LimitedBUY1,030,937199.83
2026-10-01Natvarsinh T ChavdaSELL423,483199.75
2026-10-01Natvarsinh T ChavdaBUY302,285194.40
2026-10-01Microcurves Trading Private LimitedSELL1,498,972200.04
2026-10-01Microcurves Trading Private LimitedBUY1,498,972199.79
2026-10-01Junomoneta Finsol Private LimitedSELL1,502,241199.10
2026-10-01Junomoneta Finsol Private LimitedBUY1,503,223198.86
2026-10-01J4S Financial Solutions LlpSELL857,633198.30
2026-10-01J4S Financial Solutions LlpBUY857,633198.02
2026-10-01Irage Broking Services LlpSELL420,664199.56
2026-10-01Irage Broking Services LlpBUY465,899199.98
2026-10-01Imc India Securities Private LimitedSELL444,824200.99
2026-10-01Imc India Securities Private LimitedBUY441,611199.32
2026-10-01Hrti Private LimitedSELL563,833197.49
2026-10-01Hrti Private LimitedBUY550,058196.72
2026-10-01Grt Strategic Ventures LlpSELL570,047198.93
2026-10-01Grt Strategic Ventures LlpBUY570,047198.85
2026-10-01Alphagrep Securities Private LimitedSELL613,390198.53
2026-10-01Alphagrep Securities Private LimitedBUY613,390198.29
No corporate actions on record.
DateTypeWhat it says
2026-09-29Shareholder meetingVoting results.
2026-09-28Shareholder meetingProceedings of Annual General Meeting held on September 28, 2026
2026-09-03Shareholder meetingNotice of Annual General Meeting to be held on September 28, 2026
2026-09-01General UpdatesPre advertisement for Notice of 7th AGM
2026-08-27Concall / analyst meetSchedule of meet
2026-08-24Board meeting outcomeOutcome of Board Meeting held on August 24, 2026.
2026-08-24UpdatesOutcome of Board Meeting - Appointment of Additional Director subject to confirmation by shareholders at the ensuing Annual General Meeting and taking...
2026-08-24AppointmentAppointment of Mrs Disha Bharpoda as Non- Executive Independent Director of the company w.e.f. August 24, 2026.
2026-08-14UpdatesFinancial results for Quarter ended June 2026.
2026-08-14Board meeting outcomeGujarat Kidney And Super Speciality Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-14Change in ManagementChange in Management
2026-08-14Statement of deviation(s) orStatement of deviation(s) or variation(s) under Reg. 32
2026-08-14Monitoring Agency ReportMonitoring Agency Report for Quarter ended June 2026
2026-08-05Reply to Clarification- FinaThe Exchange had sought clarification from Gujarat Kidney And Super Speciality Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33...
2026-08-03Clarification - Financial ReThe Exchange has sought clarification from Gujarat Kidney And Super Speciality Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33...
2026-07-23Shareholder meetingNotice of Postal Ballot
2026-07-21AppointmentAppointment of Mr as Other of the company w.e.f. July 09, 2026.
2026-07-10Reply to Clarification- FinaThe Exchange had sought clarification from Gujarat Kidney And Super Speciality Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33...
2026-07-09AcquisitionAcquisition of 51% of Blue Tree Clinics LLC
2026-07-09AppointmentAppointment of as Non- Executive Independent Director of the company w.e.f. July 09, 2026.
2026-07-06Shareholder meetingSubmission of Proceeding, Scrutinizer Report
2026-06-25Clarification - Financial ReThe Exchange has sought clarification from Gujarat Kidney And Super Speciality Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33...
2026-06-04Shareholder meetingNotice of Postal Ballot
2026-05-28Change in ManagementChange in Management
2026-05-28Change in ManagementChange in Management
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Close to Close price movement greater than 75perc in previous 6 monthsHigh low price variation greater than 100perc in previous 6 monthsScrip PE is greater than 50 (4 trailing quarters)
Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.Updated 2026-10-03